Trial Profile
Goal Achievement of A1c and LDL in a Randomized Trial Comparing Colesevelam vs. Ezetimibe as Add-on to Baseline Statin Therapy: The GOAL-RCT Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary) ; Ezetimibe
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GOAL-RCT
- 18 Mar 2019 Status changed from active, no longer recruiting to completed.
- 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
- 15 Nov 2017 Status changed from recruiting to active, no longer recruiting according to results presented at the 90th Annual Scientific Sessions of the American Heart Association.